Understanding Immune Reconstitution Inflammatory Syndrome in HIV/AIDS and Tuberculosis
Author Information
Author(s): Shankar Esaki Muthu, Vignesh Ramachandran, Murugavel Kailapuri G, Balakrishnan Pachamuthu, Sekar Ramalingam, Lloyd Charmaine AC, Solomon Suniti, Kumarasamy Nagalingeswaran
Primary Institution: YRG Centre for AIDS Research and Education, VHS Hospital Campus, Chennai, India
Hypothesis
The study hypothesizes that proinflammatory cytokines produced in response to systemic bacterial LPS may lead to clinical deterioration in HIV/AIDS patients with tuberculosis.
Conclusion
The study suggests that excessive proinflammatory cytokines in response to bacterial LPS can lead to immune reconstitution inflammatory syndrome (IRIS) in HIV/AIDS patients.
Supporting Evidence
- Immune reconstitution inflammatory syndrome (IRIS) occurs in HIV-infected patients during the initial months of highly active antiretroviral treatment (HAART).
- Chronic inflammation due to microbial translocation is linked to immune activation in HIV-infected individuals.
- Defective FOXP3+ gene may increase the risk of developing IRIS.
Takeaway
When people with HIV and tuberculosis start treatment, their immune system can sometimes overreact, causing more problems instead of helping them get better.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website